Loading candles…
Fredun Pharmaceuticals Ltd, incorporated in 1987 and headquartered in Mumbai, operates in the pharmaceuticals and healthcare industries. The company manufactures and exports healthcare and pharmaceutical products, focusing on generic formulations, pet healthcare, nutraceuticals, and cosmeceuticals. It maintains a branded portfolio and emphasizes exports, with a global presence spanning 52 countries including India. No information is available on its founders, key management, subsidiaries, listings, or specific projects.
This page is a live market overview for Fredun Pharmaceuticals Limited (FREDUN) on the BSE. As a listed security, Fredun Pharmaceuticals Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for FREDUN before placing trades on tick2trade.
As of the latest feed, FREDUN last traded at ₹1,244.2 on BSE, up ₹22.4 (1.83%) from the previous close of ₹1,221.8. Today's session range is ₹1,189 – ₹1,265, against a 52-week band of ₹635 – ₹1,971.25. Traded volume today stands at 29.97K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for FREDUN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether FREDUN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Fredun Pharmaceuticals Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in FREDUN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated FREDUN option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.